GenEp

GenEp, Inc. is a privately held preclinical-stage biotechnology company based on intellectual property assets licensed from the University of Virginia. GenEp's goal is to create therapies targeting mutations in sodium and other ion channels to develop treatments that address unmet needs for epilepsy patients.